Large-scale testing (Phase 3)Ended earlyNCT04572243What this trial is testingLorcaserin as Adjunctive Treatment in Participants With Dravet SyndromeWho this might be right forEpilepsies, Myoclonic Eisai Inc. 22
Testing effectiveness (Phase 2)Study completedNCT03650452What this trial is testingA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome Takeda 141
Large-scale testing (Phase 3)Looking for participantsNCT04462770What this trial is testingEPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeWho this might be right forDravet Syndrome Epygenix 150
Large-scale testing (Phase 3)Ended earlyNCT04485104What this trial is testingAssessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresWho this might be right forSeizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome Jazz Pharmaceuticals 3